183 related articles for article (PubMed ID: 18958757)
41. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
[TBL] [Abstract][Full Text] [Related]
42. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
43. In utero hematopoietic stem cell transplants for inherited diseases.
Cowan MJ; Golbus M
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):35-42. PubMed ID: 7906103
[TBL] [Abstract][Full Text] [Related]
44. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
45. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells.
Miyake T; Inaba M; Fukui J; Ueda Y; Hosaka N; Kamiyama Y; Ikehara S
Clin Exp Immunol; 2008 Apr; 152(1):153-62. PubMed ID: 18307515
[TBL] [Abstract][Full Text] [Related]
46. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells.
Ichioka N; Inaba M; Kushida T; Esumi T; Takahara K; Inaba K; Ogawa R; Iida H; Ikehara S
Stem Cells; 2002; 20(6):542-51. PubMed ID: 12456962
[TBL] [Abstract][Full Text] [Related]
47. Bone marrow transplantation for therapy in autoimmune disease.
Exner BG; Groninger JH; Ildstad ST
Stem Cells; 1997; 15 Suppl 1():171-5; discussion 175-6. PubMed ID: 9368338
[TBL] [Abstract][Full Text] [Related]
48. Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.
Sykes M; Sharabi Y; Sachs DH
Bone Marrow Transplant; 1988 Sep; 3(5):379-86. PubMed ID: 3056545
[TBL] [Abstract][Full Text] [Related]
49. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
Ohajekwe OA; James T; Hardy MA; Oluwole SF
Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
[TBL] [Abstract][Full Text] [Related]
50. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
51. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
52. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
53. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
54. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
[TBL] [Abstract][Full Text] [Related]
55. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
[TBL] [Abstract][Full Text] [Related]
56. Extensive studies on perfusion method plus intra-bone marrow-bone marrow transplantation using cynomolgus monkeys.
Inaba M; Adachi Y; Hisha H; Hosaka N; Maki M; Ueda Y; Koike Y; Miyake T; Fukui J; Cui Y; Mukaide H; Koike N; Omae M; Mizokami T; Shigematsu A; Sakaguchi Y; Tsuda M; Okazaki S; Wang X; Li Q; Nishida A; Ando Y; Guo K; Song C; Cui W; Feng W; Katou J; Sado K; Nakamura S; Ikehara S
Stem Cells; 2007 Aug; 25(8):2098-103. PubMed ID: 17495108
[TBL] [Abstract][Full Text] [Related]
57. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
Har-Noy M; Slavin S
Med Hypotheses; 2008; 70(6):1186-92. PubMed ID: 18054441
[TBL] [Abstract][Full Text] [Related]
58. Caspase inhibitor ZVAD-fmk facilitates engraftment of donor hematopoietic stem cells in intra-bone marrow-bone marrow transplantation.
Imai Y; Adachi Y; Shi M; Shima C; Yanai S; Okigaki M; Yamashima T; Kaneko K; Ikehara S
Stem Cells Dev; 2010 Apr; 19(4):461-8. PubMed ID: 19686047
[TBL] [Abstract][Full Text] [Related]
59. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
60. New strategies for allogeneic bone marrow transplantation and organ allografts.
Ikehara S
Acta Haematol; 1999; 101(2):68-77. PubMed ID: 10202236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
